Search

everythinglearnresearchcommunity

for

Search:↓

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Neurosteroids show promise for treating epilepsy and more research is needed.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Finasteride affects brain processes related to neurotransmission and metabolism, potentially helping with neuropsychiatric conditions.

Eating dairy and high glycemic foods may increase the risk of acne.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Lifestyle changes and clomiphene are first-line treatments for infertility in women with PCOS, with other options available if these fail.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.